Unlock instant, AI-driven research and patent intelligence for your innovation.

Compound containing tauzaserti structure and its preparation method and use

A technology of tauzaserti and compounds, which is applied in the fields of compounds containing tauzaseri structures and their preparation and application, can solve problems such as loss of vision function and poor effect, and achieve easy dissolution, excellent effect, and drug treatment effect Good results

Active Publication Date: 2017-10-17
杨子剑
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, glaucoma is mainly treated from two aspects. One is to reduce intraocular pressure, and its mechanism of action is to reduce intraocular pressure by promoting aqueous humor drainage, reducing aqueous humor production and hyperosmotic dehydration; the other is to protect the optic nerve. Ultimately leading to loss of visual function, optic nerve protection treatment measures include lowering intraocular pressure, using calcium antagonists, antioxidants, immunotherapy, complementary and replacement therapy, potential cell repair and gene therapy, not all optic nerve protection methods can be used clinically, Many are still in the stage of experimental research, and their effects are not good

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound containing tauzaserti structure and its preparation method and use
  • Compound containing tauzaserti structure and its preparation method and use
  • Compound containing tauzaserti structure and its preparation method and use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] 1) The mixture of 50 g of sebacic acid in 500 ml of acetic anhydride is refluxed to form acetyl-sebacic acid;

[0032] 2) 6.5g of methoxypolyethylene glycol amine, 68mg of citric acid, 160mg of dicyclohexylcarbodiimide and 8.2mg of pyridine were mixed and added into 32ml of dichloromethane, stirred at room temperature overnight; then washed with ether, and Drying at lower temperature, obtains polymkeric substance;

[0033] 3) Mix the products of step 1) and step 2) into a flask, and conduct a solution polymerization reaction under reduced pressure at 180°C for 1 hour; when the polymer is cooled to room temperature, it is dissolved in chloroform, washed with petroleum ether and dried;

[0034] 4) Put 200mg of Tauzarasete and 800mg of the polymer in step 3 into 10ml of dimethyl sulfoxide and 10ml of dichloromethane solution for 48 hours; ultrasonic for 5 minutes; then put it in an oven for 1 hour; Stir in a homogenizer at 20°C for 3 minutes at ultra-high speed, then put ...

Embodiment 2

[0036] 1) Mix 3 g of methoxypolyethylene glycol amine, 45 mg of citric acid, 200 mg of dicyclohexylcarbodiimide and 6 mg of pyridine, add 20 ml of methylene chloride, stir overnight at room temperature; then wash with ether and dry under vacuum ;

[0037] 2) Mix 20 g of acetyl-sebacic acid (commercially available) and the product of step 1 into a flask, and react at 170°C for 1.5 hours; the polymer is cooled to room temperature and dissolved in chloroform, washed with petroleum ether and dried to obtain Polymer (the structure may be slightly different from the self-made one, and the molecular weight may be different due to commercial quality);

[0038] 3) Put 30mg of Tauzatase and 150mg of the polymer into a solution mixed with 1ml of methanol and 1ml of dichloromethane; ultrasonic for 2 minutes; then put in an oven for 24 hours; at minus 10-20 degrees, homogeneous The product was stirred at high speed for 2 minutes, and the product was put into 3% cholic acid solution and st...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a new compound containing a tauzaseti structure, a preparation method and an application of the compound. The drug prepared from the new compound containing tauzasertine structure has better effects on treating glaucoma diseases and protecting optic nerve than other drugs or medicines.

Description

technical field [0001] The invention discloses a new compound containing a tauzaseti structure, a preparation method and an application of the compound. Background technique [0002] Tozasertib (English: Tozasertib; chemical name: N-[4-[[4-(4-methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazole-3- Base) amino]-2-pyrimidinyl]sulfur]phenyl]cyclopropanecarboxamide; alias: MK 0457 or VX 680, is an anti-tumor drug discovered in recent years, and its effect on nerves and glaucoma has been reported later .As of 2012, 65 million people in the world suffer from glaucoma, of which 45 million are primary open-angle glaucoma and 15 million are primary angle-closure glaucoma One of the main blinding factors of glaucoma is the increase of intraocular pressure (IOP). At present, glaucoma is mainly treated from two aspects. One is to reduce intraocular pressure. Aqueous humor generation and hypertonic dehydration reduce intraocular pressure; the second is to protect the optic nerve, glaucoma op...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C08G63/91C08G63/688C08G65/48C07D403/12A61K31/795A61K47/60A61K47/59A61K31/506A61K9/14A61K9/16A61P27/02A61P25/00A61P27/06
Inventor 杨子剑杨静高强
Owner 杨子剑